Filters
Term Search
You can select from the dropdown list OR enter your own terms to refine the search.
Last Updated: 10/31/2025
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 561 publications
Erratum to "Autophagy inhibition enhances sensitivity of alpelisib in PI3K-mutated non-small cell lung cancer" [Biomed. Pharmacother. 192 (2025), 118620].
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: October 17, 2025
USP10/GSK3B-mediated inhibition of PTEN drives resistance to PI3K inhibitors in breast cancer.
Journal: The Journal of clinical investigation
Published: September 24, 2025
Complete Response With Alpelisib and Trastuzumab in a Patient With Estrogen Receptor-/Progesterone Receptor-Negative, Human Epidermal Growth Factor Receptor 2-Positive Refractory Metastatic Breast Cancer.
Journal: JCO precision oncology
Published: September 17, 2025
Conventional and alternative approaches for targeting PIK3CA and PTEN alterations in head and neck, breast, and other cancers.
Journal: Advances in biological regulation
Published: September 04, 2025
Structural Insights into the Development of Inhibitors Against Cancer-Specific Mutations of PI3Kα.
Journal: Annual review of pharmacology and toxicology
Published: August 19, 2025
Precise regulation of RAS-Mediated PI3Kα activation: therapeutic potential of BBO-10203 in cancer treatment.
Journal: Experimental hematology & oncology
Published: July 26, 2025
Primary Analysis of EPIK-O/ENGOT-ov61: Alpelisib Plus Olaparib Versus Chemotherapy in Platinum-Resistant or Platinum-Refractory High-Grade Serous Ovarian Cancer Without BRCA Mutation.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: July 23, 2025
Integrated In Silico and Experimental Validation of Antrocin as a Plant-Derived Multi-Target Therapeutic for BRAF/MEK/PI3K-Driven Colorectal Cancer.
Journal: International journal of molecular sciences
Published: July 17, 2025
Autophagy inhibition enhances sensitivity of alpelisib in PI3K-mutated non-small cell lung cancer.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: July 17, 2025
Efficacy and safety of systemic therapies following progression on CDK4/6 inhibitors in patients with HR+/HER2- metastatic breast cancer: a systematic review and network meta-analysis.
Journal: EClinicalMedicine
Published: July 15, 2025
Last Updated: 10/31/2025